e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Regulation of immunological and inflammatory reactions in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inflammatory mediators release from asthmatic and non-asthmatic bronchial epithelial cells (BEC) following infection with rhinovirus (RV)
P. A. Wark, B. Fabio, S. T. Holgate, S. L. Johnston, D. E. Davies (Southampton, London, United Kingdom)
Source:
Annual Congress 2005 - Regulation of immunological and inflammatory reactions in asthma and COPD
Session:
Regulation of immunological and inflammatory reactions in asthma and COPD
Session type:
Poster Discussion
Number:
296
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. A. Wark, B. Fabio, S. T. Holgate, S. L. Johnston, D. E. Davies (Southampton, London, United Kingdom). Inflammatory mediators release from asthmatic and non-asthmatic bronchial epithelial cells (BEC) following infection with rhinovirus (RV). Eur Respir J 2005; 26: Suppl. 49, 296
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Difference between normals and asthmatics in bronchial inflammatory infiltrate following experimental rhinovirus 16 (RV16) infection
in vivo
Source: Eur Respir J 2001; 18: Suppl. 33, 532s
Year: 2001
Interferon-β response to rhinovirus infection in bronchial epithelial cells from asthmatic children
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Cytotoxic effects of infection with Rhinovirus comparing asthmatic and normal primary bronchial epithelial cells (PBEC)
Source: Eur Respir J 2003; 22: Suppl. 45, 458s
Year: 2003
Rhinovirus infection in nonasthmatic subjects: effects on intrapulmonary airways
Source: Eur Respir J 2002; 20: 274-279
Year: 2002
Investigating the effects of interleukin-33 on rhinovirus A induced changes in asthmatic bronchial epithelial cells
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020
Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells
Source: Eur Respir J 2012; 40: 122-132
Year: 2012
Effects of chronic exposure to IL-13 on mucociliary differentiation of epithelial cells obtained from asthmatic and non-asthmatic children
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Chemokine release in response to
Streptococcus pneumoniae
, by primary bronchial epithelial cells of patients with severe asthma and healthy controls
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
Distribution and degranulation of airway mast cells in normal and asthmatic subjects
Source: Eur Respir J 2002; 19: 879-885
Year: 2002
Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011
Inflammatory cells and cytokines in bronchial biopsies of asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 398s
Year: 2003
Establishing the effects of chronic exposure to IL-9 alone and in combination with IL-13 on the differentiation of asthmatic and non-asthmatic paediatric bronchial epithelial cells
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion
Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018
Year: 2018
Ozone induced bronchial epithelial cytokine expression differs between asthmatic and healthy subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 22s
Year: 2002
Inflammatory cell activation in eosinophilic and non-eosinophilic asthma
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006
Elucidating the cellular responses of healthy and cystic fibrosis (CF) airway epithelial cells in response to non-viral stimuli and human rhinoviral (HRV) infection
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010
Comparative responses of upper and lower airway epithelial cells to inflammatory stimulation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 338s
Year: 2006
Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 32s
Year: 2001
Investigation of the CFTR-TGFß1 interaction in inflammatory and fibrotic processes in healthy and CFTR-mutated human bronchial epithelial cells
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept